# FDA Warning Letter: Cohance Lifesciences Limited
> 2026-02-03 · Center for Drug Evaluation and Research (CDER) · `cb7222f0a68236ec`
## Letter
- **Company:** Cohance Lifesciences Limited
- **Posted Date:** 2026-02-03
- **Letter Issue Date:** 2026-01-30
- **Issuing Office:** Center for Drug Evaluation and Research (CDER)
## Subject
CGMP/Finished Pharmaceuticals/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*